Table 1

Studies analysing surgical smoke for the presence of HPV DNA or viable infectious material

Study noAuthor/yearStudy designSample sizeFindings
1Bellina 198228 Surgical smoke from CO2 laser ablation of adult female condylomata acuminata lesions was analysed for the presence of viable material using in vitro metabolic studies.8 samplesNo evidence of metabolic activity, DNA replication activity or RNA transcription activity in smoke.
2Garden198829 Surgical smoke from CO2 laser ablation of plantar or mosaic verrucae was analysed for the presence of HPV DNA using a Southern Blot hybridisation technique.7 patientsHPV DNA was detected in tissue samples from 6/7 patients and in the smoke samples from 2/7 patients.
3Sawchuk 198930 Surgical smoke from CO2 laser ablation or electrocoagulation of plantar warts was analysed for the presence of HPV DNA using a dot-blot analysis technique.8 patientsHPV DNA was detected in 5/8 laser-derived smoke samples and 4/7 electrocoagulation-derived smoke samples.
4Andre 199031 Surgical smoke from CO2 laser ablation of genital condylomata was analysed for the presence of HPV DNA using a Southern Blot hybridisation technique.3 patientsHPV6 DNA was detected in 2/3 smoke samples and in the corresponding tissue samples.
5Abramson 199032 Surgical smoke from CO2 laser ablation of adult and child recurrent laryngeal papillomas was analysed for the presence of HPV DNA using a Southern Blot hybridisation technique.7 patientsHPV DNA was detected in 0/5 smoke samples.
6Ferenczy 199033 Surgical smoke from CO2 laser ablation of genital lesions was analysed for the presence of HPV DNA using a filter hybridisation technique.110 patientsHPV DNA was detected in 65/110 tissue samples, 1/5 smoke filters and 0/4 vacuum tubes.
7Kashima 199134 Surgical smoke from CO2 laser ablation of laryngeal papillomas in patients with RRP was analysed for the presence of HPV DNA using an HPV6 and HPV11-specific PCR.22 patientsHPV6 or HPV11 DNA was detected in 23/27 tissue samples and 17/30 smoke samples, with the HPV subtypes detected in smoke matching those detected in the corresponding tissue samples.
8Sood 199435 Surgical smoke from LEEP of cervical lesions was analysed for the presence of HPV DNA using PCR.49 patientsHPV DNA was detected in 39/49 tissue samples, and 18/49 smoke samples, with the HPV subtypes detected in smoke matching those detected in the corresponding tissue samples.
9Kunachak 199636 Porcine and human cell lines were inoculated with surgical smoke from CO2 laser ablation of laryngeal papilloma samples to determine if HPV transmission can occur in vitro.10 tissue samplesCell lines exposed to surgical smoke did not demonstrate evidence of viral infection.
10Hughes 199837 Surgical smoke from erbium:YAG laser ablation of verrucae vulgares tissue samples was analysed for the presence of HPV DNA using an HPV2-specific PCR.5 tissue samplesHPV2 DNA was detected in 5/5 tissue samples and 0/5 smoke samples.
11Weyandt 201138 Surgical smoke from CO2 laser ablation of genital warts was analysed for the presence of HPV DNA using PCR.10 samplesHPV6 DNA was detected in 3/10 smoke filters and in the corresponding tissue samples.
12Akbarov 201339 Surgical smoke from holmium:YAG laser ablation of genital warts was analysed for the presence of HPV DNA using PCR.66 patientsHPV DNA was detected on 66/66 standard surgical masks used to filter extracted surgical smoke.
13Neumann 201740 Surgical smoke from LEEP of cervical lesions was analysed for the presence of HPV DNA using a PCR specific for 30 HPV subtypes.24 patientsHPV DNA was detected in 4/24 smoke samples, with the HPV subtypes detected matching those detected in the corresponding tissue samples.
14Zhou 201941 Surgical smoke from LEEP of cervical lesions was analysed for the presence of HPV DNA using a combination of PCR and a flow fluorescence in situ hybridisation technique.134 patientsHPV DNA was detected in 30/134 and 40/134 smoke samples using PCR and fluorescence hybridisation respectively, with the HPV subtypes detected matching those detected in the corresponding tissue samples.
  • CO2, carbon dioxide; HPV, human papillomavirus; LEEP, loop electrosurgical excision procedure; RRP, recurrent respiratory papillomatosis; YAG, yttrium-aluminium-garnet.